Background: Postsynaptic cholinergic deficits, including reduced cortical muscarinic M1 receptor coupling to G-proteins, are neurochemical findings postulated to underlie the limited efficacy of presynaptically-targeted cholinergic replacement therapies in Alzheimer's disease (AD). While the loss of M1-G-protein coupling has been associated with ␤-amyloid (A␤) burden in AD, the status of M1 coupling to G-proteins in Parkinson's disease-related or mixed dementias is unclear. Objective: To test the hypothesis that M1 receptor uncoupling is correlated with A␤ burden, we aimed to study muscarinic M1 neurochemical parameters in neurodegenerative dementias characterized by low and high A␤ loads. Methods: M1 receptors, M1 coupling to G-proteins as well as A␤ were measured in postmortem frontal cortex of a cohort of longitudinally assessed patients with Parkinson's Disease Dementia (PDD, low A␤ load) and AD with significant subcortical cerebrovascular disease (AD + CVD, high A␤ load). Results: We found unchanged levels of M1 receptors in both dementia groups, while M1 coupling was reduced only in AD + CVD (p < 0.01). Furthermore, A␤ concentration was significantly increased only in AD + CVD, and correlated negatively with M1-G-protein coupling in the dementia groups. Conclusions: Our study suggests that loss of M1 coupling to G-proteins may be a neurochemical feature of neurodegenerative dementias with high cortical A␤ burden, and that cholinergic replacement therapies may be more efficacious for PDD due to low A␤ burden.
